Safety of ciprofloxacin based on phase IV studies ("Anwendungsbeobachtung") in the Federal Republic of Germany.
Reiter
C
C
Institute of Drug Safety, Bayer AG, Wuppertal, Federal Republic of Germany.
Pfeiffer
M
M
Hullman
R N
RN
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001424:Bacterial Infections / Q000188:drug therapy; D002648:Child; D002939:Ciprofloxacin / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012449:Safety; D011795:Surveys and Questionnaires
D002939:Ciprofloxacin